Pmv Pharmaceuticals, Inc. (PMVP) SEC Filings — 2025
7 SEC filings for Pmv Pharmaceuticals, Inc. (PMVP) in 2025.
Filings
- PMVP's Losses Widen Amid Increased R&D Spend; Cash Dwindles — 10-Q · Nov 12, 2025
- PMV Pharmaceuticals Files 8-K with Exhibits — 8-K · Sep 10, 2025
- PMVP Narrows Q2 Loss to $30.2M Amid R&D Spend Cuts — 10-Q · Aug 7, 2025
- PMV Pharmaceuticals Files 8-K on Shareholder Votes — 8-K · Jun 9, 2025
- PMV Pharmaceuticals Files 10-Q for Q1 2025 — 10-Q · May 9, 2025
- PMV Pharmaceuticals Files Definitive Proxy Statement — DEF 14A · Apr 25, 2025
- PMV Pharmaceuticals Files 2024 10-K — 10-K · Mar 3, 2025